Cargando…
Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”
Spot baseline urinary monoamine assays have been used in medicine for over 50 years as a screening test for monoamine-secreting tumors, such as pheochromocytoma and carcinoid syndrome. In these disease states, when the result of a spot baseline monoamine assay is above the specific value set by the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165907/ https://www.ncbi.nlm.nih.gov/pubmed/21912487 http://dx.doi.org/10.2147/IJNRD.S22783 |